CSNK2A3 Antikörper (AA 151-391) (FITC)
-
- Target Alle CSNK2A3 Produkte
- CSNK2A3 (Casein Kinase 2, alpha 3 Polypeptide (CSNK2A3))
-
Bindungsspezifität
- AA 151-391
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CSNK2A3 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Casein kinase II subunit alpha 3 protein (151-391AA)
- Isotyp
- IgG
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CSNK2A3 (Casein Kinase 2, alpha 3 Polypeptide (CSNK2A3))
- Andere Bezeichnung
- CSNK2A3 (CSNK2A3 Produkte)
- Synonyme
- CK II alpha 3 antikoerper, CSNK2A1P antikoerper, casein kinase 2 alpha 3 antikoerper, CSNK2A3 antikoerper
- Hintergrund
-
Background: Probable catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Amplification-dependent oncogene, promotes cell proliferation and tumorigenesis by down-regulating expression of the tumor suppressor protein, PML. May play a role in the pathogenesis of the lung cancer development and progression.
Aliases: CSNK2A3 antibody, CSNK2A1PCasein kinase II subunit alpha 3 antibody, CK II alpha 3 antibody, EC 2.7.11.1 antibody, Casein kinase II alpha 1 polypeptide pseudogene antibody
- UniProt
- Q8NEV1
-